Post by BioThrust

💙 𝗕𝗶𝗼𝗧𝗵𝗿𝘂𝘀𝘁 𝘀𝗲𝗰𝘂𝗿𝗲𝘀 €𝟮 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝘃𝗶𝗮 𝗚𝗢-𝗕𝗶𝗼 𝘯𝘦𝘹𝘵 𝘁𝗼 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘀𝗰𝗮𝗹𝗲𝗱 𝘀𝘁𝗲𝗺 𝗰𝗲𝗹𝗹 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴! We are excited to announce that the German Federal Ministry of Research, Technology and Space (Bundesministerium für Bildung und Forschung) has allocated €1,957,750 to BioThrust to fund Project KISSEN as part of GO-Bio 𝘯𝘦𝘹𝘵 Phase II, managed by the Projektträger Jülich, Forschungszentrum Jülich GmbH. 🎉 🔬 𝗪𝗵𝗮𝘁 𝘄𝗶𝗹𝗹 𝘄𝗲 𝘂𝘀𝗲 𝘁𝗵𝗲𝘀𝗲 𝗳𝘂𝗻𝗱𝘀 𝗳𝗼𝗿? With this support, we will scale our stem-cell-optimized Single-Use ComfyCell bioreactor vessels to 10 L and beyond (up to 50 L). We will also explore novel flat sheet membrane materials and technologies to further improve gas transfer, simplify cell culture handling, and streamline the manufacturing process. 🎯 𝗢𝘂𝗿 𝗼𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲𝘀: ➡️ Achieve 6–10× higher gas transfer to unlock new efficiency levels for stem cell cultivation and enable true high-density scalability ➡️ Considerably reduce cost per dose for groundbreaking cell therapies, including those targeting Type 1 diabetes, Parkinson’s disease, and heart failure. 👉 Official BMFTR press release: https://lnkd.in/eCRSftBT 👉 KISSEN project summary: https://lnkd.in/eCJFGdfF Thank you to everyone involved from the PTJ, especially Ute Fink, Alexander Damaschun & Natalie Feiler. 𝗪𝗲 𝗮𝗿𝗲 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿𝘄𝗮𝗿𝗱 𝘁𝗼 𝗺𝗮𝗸𝗶𝗻𝗴 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗳𝗼𝗿 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲!